SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-191601
Filing Date
2024-08-01
Accepted
2024-08-01 17:01:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d821617d424b5.htm 424B5 253644
2 GRAPHIC g821617g01d01.jpg GRAPHIC 56841
3 GRAPHIC g821617g08c88.jpg GRAPHIC 51911
  Complete submission text file 0001193125-24-191601.txt   400236
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277753 | Film No.: 241167663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)